Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel vs Ifosfamide and Doxorubicin in Localized Soft Tissue Sarcoma
NCT00189137Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2004
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in soft tissue sarcoma (STS), sponsored by University of Michigan Rogel Cancer Center. Started Aug 2004; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00189137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00189137.